e-Drug3D 689 |
cas 146961-76-4 |
CLASS ANTIINFECTIVES |
ROUTE (list) INJECTION |
ATC code |
PK parameters |
Target TARGET DNA GYRASE SUBUNIT A |
DrugCentral Topoisomerase IV UNIPROT P0AFI2 parC DNA gyrase UNIPROT P0AES4 gyrA |
Download SDF file | L-Alaninamide, L-alanyl-N-[(1.alpha.,5.alpha.,6.alpha.)-3-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl]- Formula: Calculated chemical properties: MW 557.51 NB_atoms 40 XLogP -0.43 PSA 147.083 NB_HD 4 NB_HA 11 fsp3 0.35 Lipinski(0=no;1=yes) 0 |
FDA NDA 020760 (pdf not found) INN (ALATROFLOXACIN MESYLATE) TROVAN PRESERVATIVE FREE (PFIZER) APPROVAL= AP YEAR= 1997 NEWMOLECULARENTITY DISCONTINUED |
Other links: | |
e-Drug3D 1276 |
cas 147059-72-1 |
CLASS ANTIINFECTIVES |
ROUTE (list) ORAL |
ATC code |
PK parameters VD 84.5 LITER (65 KILOGRAM) |
Target TARGET DNA GYRASE SUBUNIT A DNA TOPOISOMERASE 4 SUBUNIT A DNA TOPOISOMERASE 2-ALPHA PDB Ligand code = TR6 (link to the list of PDB complexes) Download experimental 3D coordinates of TR6 with added hydrogens |
DrugCentral Topoisomerase IV UNIPROT P0AFI2 parC DNA gyrase UNIPROT P0AES4 gyrA |
Download SDF file | 7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Formula: Calculated chemical properties: MW 415.35 NB_atoms 30 XLogP 0.56 PSA 89.254 NB_HD 2 NB_HA 7 fsp3 0.25 Lipinski(0=no;1=yes) 1 |
Other links: |